T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.94B |
| 2 |
Broadcom
AVGO
|
+$2.74B |
| 3 |
Microsoft
MSFT
|
+$2.33B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.47B |
| 5 |
GE Aerospace
GE
|
+$1.27B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.42B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$2.44B |
| 3 |
Apple
AAPL
|
+$2.42B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.3B |
| 5 |
Eli Lilly
LLY
|
+$1.78B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.73% |
| 2 | Financials | 12.11% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 10.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Teekay
TK
$1.24B
| $209K | ﹤0.01% |
25,257
+2,050
| +9% | +$15.9K |
|
2677
Inogen
INGN
$143M
| $208K | ﹤0.01% |
29,460
+1,660
| +6% | +$11.2K |
|
2678
Medifast
MED
$133M
| $208K | ﹤0.01% |
14,793
+520
| +4% | +$6.83K |
|
2679
Lindblad Expeditions
LIND
$1.89B
| $207K | ﹤0.01% |
17,709
+2,089
| +13% | +$20.7K |
|
2680
Frontier Group Holdings
ULCC
$1.38B
| $207K | ﹤0.01% |
56,828
+24,315
| +75% | +$89.1K |
|
2681
Arhaus
ARHS
$1.36B
| $206K | ﹤0.01% |
23,743
+1,518
| +7% | +$12.7K |
|
2682
Choiceone Financial
COFS
$489M
| $206K | ﹤0.01% |
+7,162
| New | +$203K |
|
2683
Delcath Systems
DCTH
$540M
| $206K | ﹤0.01% |
+15,078
| New | +$210K |
|
2684
Climb Global Solutions
CLMB
$592M
| $205K | ﹤0.01% |
+7,656
| New | +$202K |
|
2685
TAL Education Group
TAL
$6.62B
| $205K | ﹤0.01% |
19,968
-10,728
| -35% | -$111K |
|
2686
MGP Ingredients
MGPI
$273M
| $204K | ﹤0.01% |
+6,782
| New | +$202K |
|
2687
Celcuity
CELC
$3.86B
| $203K | ﹤0.01% |
15,186
+1,054
| +7% | +$11.5K |
|
2688
Telos
TLS
$305M
| $203K | ﹤0.01% |
63,800
+5,010
| +9% | +$13K |
|
|
BKV
2689
BKV Corp
BKV
$2.39B
| $203K | ﹤0.01% |
+8,389
| New | +$173K |
|
|
KALV
2690
DELISTED
KalVista Pharmaceuticals
KALV
| $202K | ﹤0.01% |
17,864
+1,041
| +6% | +$12.7K |
|
2691
KVH Industries
KVHI
$133M
| $202K | ﹤0.01% |
37,763
| – | – |
|
|
MAGN
2692
Magnera Corp
MAGN
$425M
| $202K | ﹤0.01% |
+16,661
| New | +$229K |
|
2693
ATN International
ATNI
$440M
| $201K | ﹤0.01% |
12,316
-123
| -1% | -$2K |
|
|
BORR
2694
Borr Drilling
BORR
$1.28B
| $201K | ﹤0.01% |
109,742
+5,618
| +5% | +$10.6K |
|
2695
Dianthus Therapeutics
DNTH
$4.91B
| $200K | ﹤0.01% |
10,692
+201
| +2% | +$3.77K |
|
2696
First Business Financial Services
FBIZ
$584M
| $200K | ﹤0.01% |
+3,935
| New | +$189K |
|
2697
Repay Holdings
RPAY
$309M
| $200K | ﹤0.01% |
41,456
+3,388
| +9% | +$15.5K |
|
2698
Bit Digital
BTBT
$613M
| $199K | ﹤0.01% |
90,862
+37,797
| +71% | +$83.5K |
|
|
NEXN
2699
Nexxen International
NEXN
$490M
| $198K | ﹤0.01% |
+18,930
| New | +$192K |
|
2700
Tango Therapeutics
TNGX
$4.12B
| $197K | ﹤0.01% |
38,401
+16,149
| +73% | +$39.9K |
|
Similar funds
T. Rowe Price Associates's Q2 2025 Portfolio in Review
As of Q2 2025, T. Rowe Price Associates held 3,193 positions worth $883B, up 8.8% from $812B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2025 filing shows 153 new, 2,010 increased, 803 reduced and 136 closed positions. Its largest new stake was Ralliant Corp: 4,667,638 shares worth $226M. The largest sale was Amazon, an estimated $3.42B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q2 2025 buy was Ralliant Corp: 4,667,638 shares worth $226M.
- T. Rowe Price Associates added most to NVIDIA in Q2 2025, an estimated $3.94B increase.
- T. Rowe Price Associates's biggest Q2 2025 reduction was Amazon, cutting an estimated $3.42B.
- T. Rowe Price Associates fully exited US Steel in Q2 2025, selling an estimated $146M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $883B portfolio in Q2 2025.
- T. Rowe Price Associates opened 153 new positions and closed 136 in Q2 2025.
- T. Rowe Price Associates's portfolio value rose 8.8% quarter-over-quarter to $883B.
Based on T. Rowe Price Associates's 13F filing for Q2 2025, filed 14 Aug 2025.